News Â鶹´«Ã½ from FAST (Foundation for Angelman Syndrome Therapeutics) Latest news from FAST (Foundation for Angelman Syndrome Therapeutics) on News en-us Copyright 2024 News News Â鶹´«Ã½ from FAST (Foundation for Angelman Syndrome Therapeutics) 115 31 / /images/newswise-logo-rss.gif Family Advocates Urge Congress' Support During Inaugural Angelman Syndrome (AS) Congressional Advocacy Day /articles/family-advocates-urge-congress-support-during-inaugural-angelman-syndrome-as-congressional-advocacy-day/?sc=rsin /articles/family-advocates-urge-congress-support-during-inaugural-angelman-syndrome-as-congressional-advocacy-day/?sc=rsin Thu, 07 Mar 2024 08:05:35 EST The Angelman Syndrome Foundation (ASF) and the Foundation for Angelman Syndrome Therapeutics (FAST) are hosting the inaugural Angelman Syndrome (AS) Congressional Advocacy Day in Washington, D.C. FAST (Foundation for Angelman Syndrome Therapeutics) FAST Conference Draws 20 Pharmaceutical Companies and Raises Over $2.2 Million for Research on Angelman Syndrome /articles/fast-conference-draws-20-pharmaceutical-companies-and-raises-over-2-2-million-for-research/?sc=rsin /articles/fast-conference-draws-20-pharmaceutical-companies-and-raises-over-2-2-million-for-research/?sc=rsin Mon, 14 Dec 2020 09:15:10 EST FAST (the Foundation for Angelman Syndrome Therapeutics) today announced that Virtually Unstoppable, their annual Summit & Gala benefitting Angelman syndrome (AS) raised over $2.2 million during their virtual two-day conference. FAST (Foundation for Angelman Syndrome Therapeutics) Penn Gene Therapy Pioneer Teams Up with FAST in Race to Cure Angelman Syndrome /articles/penn-gene-therapy-pioneer-teams-up-with-fast-in-race-to-cure-angelman-syndrome/?sc=rsin /articles/penn-gene-therapy-pioneer-teams-up-with-fast-in-race-to-cure-angelman-syndrome/?sc=rsin Tue, 14 Feb 2017 15:05:23 EST A pioneer on the frontier of genetic medicine and his team at one of the nation's top-five medical research schools have joined forces with FAST (Foundation for Angelman Syndrome Therapeutics) to develop a treatment for the rare disorder Angelman syndrome. FAST (Foundation for Angelman Syndrome Therapeutics)